课题基金 / 基金详情

Self-driven, dynamic real-world haptic assessment for optimal pain management in the community and clinic.

Self-driven, dynamic real-world haptic assessment for optimal pain management in the community and clinic.
自我驱动、动态的现实世界触觉评估,以实现社区和诊所的最佳疼痛管理。
批准号:
10042734
负责人:
金额:
$5.71万
依托单位:
依托单位国家:
英国
项目类别:
Grant for R&D
财政年份:
2022
资助国家:
英国
项目状态:
已结题
起止时间:
2022 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
Neurotact创造了首个此类新型触觉设备,可以对疼痛进行全面评估,并为每个患者提供个性化记录。它是唯一一个有形的疼痛评估工具(通过使用触摸)。它易于使用,并通过使用Neurotact的人工智能驱动的数据分析和疼痛可视化将患者放在驾驶座上。它的设计是直观的,避免了使用问卷,使其成为一种快速而轻松的体验。Neurotact提供了为每个用户校准评估的能力。使用触觉的手持可操作设备,采用多维传感器数据,通过时间测量疼痛,并允许用户将他们的疼痛可视化为疼痛信号。使用人工智能支持的平台。Neurotact提供全面的疼痛评分、治疗结果和疼痛行为变化预测。世界上每个临床机构的患者每天都被要求报告他们的疼痛(强度、位置、严重程度、持续时间、影响)。考虑到这项任务是如此普遍,令人惊讶的是,尽管有很好的记录的缺点,疼痛评估工具在过去的50年里并没有发生有意义的变化。目前的疼痛评估要求患者减少他们的体验,并将其转换为口头(使用严重、轻度、中等)或数字表示(从1到10)。这种简单化迫使痛苦的复杂性质变成了一个过于简单化的“标记”,牺牲了所有丰富的信息。这种简单化是患者非常讨厌的。Neurotact为患者提供了将自己的疼痛信号可视化的能力。重要的是,它可以在家中使用,也可以在移动中使用。它将疼痛评估从临床中解放出来,并将权力还给了可以在疼痛发生时进行评估的个人。患者和临床医生可以一起定制他们的治疗并监控与治疗相关的变化,将评估重新置于患者的控制之下。此外,还可以聚合患者的数据,以构建与特定环境(例如癌症疼痛、手术后疼痛、慢性疼痛)相关的患者疼痛体验的表型。这些模式可以让临床医生更好地了解常见的患者疼痛路径,从而实现更智能的治疗定制。Neurotact是一项可投资的英国创新,可以为疼痛患者提供自我驱动的医疗解决方案,试图评估疼痛何时以及如何变得无法控制。
英文摘要
Neurotact created the first-of-its kind novel haptic device that assesses pain holistically and offers a personalised record for each patient. It is the only pain assessment tool that is tangible (by employing touch). It is easy to use and puts the patient in the driving seat by using Neurotact's AI-driven data analytics and pain visualisation. It is designed to be intuitive and avoids the use of questionnaires, making it a quick and easy experience. Neurotact offers the ability to calibrate assessment for each user. Using a tactile hand-held manipulable device employing multidimensional sensor data and measures pain through time and allows users to visualise their pain as a pain signature. With an AI-powered platform. Neurotact provides a comprehensive pain score, treatment outcome and pain behaviour change predictions.Every day in every clinical facility in the world patients are asked to report on their pain (intensity, location, severity, duration, impact). Given how common this task is, it is surprising that pain assessment tools haven't meaningfully changed in the last fifty years, despite well-documented shortcomings. Current pain assessment requires patients to reduce and transform their experience into a verbal (using words such as severe, mild, moderate) or numerical representation (from 1-10). This simplification forces the complex quality of pain into an oversimplified 'mark' that sacrifices all of the rich information. This simplification is much hated by patients.Neurotact offers individuals the ability to visualise their own pain signature. Importantly, it can be used at home or on the move. It liberates pain assessment from the clinic and gives the power back to the individual who can assess pain as it is happening. Together patients and clinicians can tailor their treatment and monitor changes associated with treatment, putting the assessment back in control of the patient.Further, data can also be aggregated across patients to build phenotypes of patient pain experience related to specific contexts (e.g. cancer pain, pain after surgery, chronic pain). These patterns can provide clinicians with a better picture of common patient pathways of pain, allowing for smarter treatment tailoring.Neurotact is an investable British innovation that can provide a self-driven healthcare solution for people living with pain, trying to assess when and how pain becomes unmanageable.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Data-driven Recommendation System Construction of an Online Medical Platform Based on the Fusion of Information
基于Cache的远程计时攻击研究